Similarly, high frequency of MEFV variants in Middle Easterners and Ashkenazi Jews have been proposed to protect against Yersinia pestis infections, CFTR and GJB2 variants against diarrhea, and CYP21A2 variants have been hypothesized to decrease mortality from pneumonia [35–38]. Here, GJB2 is linked to pneumonia.